The G037 pill is a high-potency prescription combination medication containing an opioid pain reliever and a non-opioid analgesic. It is widely prescribed under brand names such as Lortab and Norco (or as a generic equivalent, typically supplied by manufacturers like Tris Pharma Inc.) to manage acute, severe pain.
Because it contains a full opioid agonist, this drug is heavily regulated by the United States Drug Enforcement Administration (DEA) as a Schedule II Controlled Substance, meaning it carries a severe risk of physiological dependence, abuse, and addiction.
Pill Identification
Accurately identifying high-alert medications is critical to maintaining clinical safety and preventing accidental overdoses.
Physical Characteristic Detail
- Imprint G 037 (clearly stamped across one face)
- Color White
- Shape Capsule -shaped / Oblong / Oval
- Form Oral Solid Tablet
- Active Composition 10 mg Hydrocodone Bitartrate / 325 mg Acetaminophen
- Therapeutic Class Opioid/Narcotic Analgesic Combination
Mechanism of Action (How It Works)
The G037 pill functions via a dual-mechanism approach. By combining a central opioid with a core non-opioid pain reliever, the formulation creates a synergistic effect, disrupting pain pathway signaling at two separate physiological junctions.
Hydrocodone Bitartrate (10 mg)
Hydrocodone is a semi-synthetic narcotic. Its main clinical mechanism involves acting as an agonist primarily targeted at the opioid receptors (receptors) in the brain and spinal cord.
- Intracellular Signaling: Binding to these receptors stimulates G-protein coupled complexes, which simultaneously suppresses adenylate cyclase activity, decreases intracellular calcium influx, and opens potassium channels.
- Sensation Modification: This cellular shift hyperpolarizes neuronal membranes, effectively dulling the transmission of incoming ascending pain signals and fundamentally altering the patient’s neurological and emotional perception of pain.
Acetaminophen (325 mg)
Acetaminophen (often abbreviated as APAP) operates largely within the central nervous system, though its exact molecular targets remain a subject of active pharmacological study.
- Prostaglandin Inhibition: It is understood to reduce prostaglandin synthesis primarily in the brain. Unlike classical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), it lacks significant peripheral anti-inflammatory traits and does not inhibit platelet aggregation or irritate the gastric mucosal lining.
- Fever Reduction: It acts directly on the hypothalamic heat-regulating center, causing the body to induce peripheral vasodilation and sweating to shed excess thermal energy.
Recommended Dosage & Administration
Dosage thresholds must be strictly adjusted by a physician based on the patient’s individual pain metrics, body weight, liver function, and history of opioid tolerance.
- Standard Adult Regimen: The baseline therapeutic dose is one tablet taken orally every 4 to 6 hours strictly as needed for acute pain management.
- Maximum Daily Ceiling: Due to the risk of profound respiratory depression and systemic toxicity, patients must never exceed 6 tablets in any 24-hour cycle.
- The 4,000 mg Acetaminophen Boundary: The maximum daily intake of acetaminophen from all concurrent medical sources (including over-the-counter cold, flu, or sinus formulations) must never exceed 4,000 mg (4 grams). Exceeding this boundary can cause sudden, catastrophic liver failure.
Side Effects
Side effects range from predictable, mild physiological changes to life-threatening complications related to central nervous system depression.
Common Side Effects
These frequently present during the initiation of therapy and may stabilize as the body adjusts:
- Profound drowsiness, lethargy, or generalized sedation
- Dizziness or lightheadedness (especially when standing up abruptly)
- Nausea, vomiting, and loss of appetite
- Constipation: Opioids intrinsically slow down gastrointestinal smooth muscle motility. Proactive stool softeners are frequently required during therapy.
- Mild skin itching (pruritus) caused by opioid-induced systemic histamine release
Severe Side Effects (Require Emergency Intervention)
- Respiratory Depression: Critically slowed, shallow, or labored breathing.
- Severe Hypotension: An acute, hazardous drop in blood pressure that can present as fainting or circulatory collapse.
- Adrenal Insufficiency: Chronic use can decrease systemic cortisol levels, causing persistent vomiting, severe exhaustion, and profound weakness.
- Severe Cutaneous Reactions: Rare but dangerous skin conditions, such as Stevens-Johnson Syndrome (SJS), marked by blistering and peeling skin.
Precautions and Boxed Warnings
The FDA places its most stringent warnings on immediate-release combination opioids like the G037 tablet due to their potential for systemic harm.
FDA Black Box Warnings
- Addiction, Misuse, and Abuse: G037 exposes users to the risks of opioid addiction, which can culminate in life-threatening respiratory failure or fatal overdose.
- Life-Threatening Respiratory Depression: Fatal respiratory depression can manifest rapidly, even when the medication is consumed exactly as directed by a physician.
- Accidental Ingestion Risk: Ingestion of even a single tablet by an unintended individual—especially a child—can result in an immediate fatal opioid overdose.
- Acute Hepatotoxicity: Acetaminophen overexposure is directly linked to acute liver failure, sometimes requiring urgent organ transplantation or resulting in death.
- Neonatal Opioid Withdrawal Syndrome (NOWS): Extended maternal use of this drug during pregnancy exposes the fetus to dangerous in-utero dependence, resulting in life-threatening withdrawal symptoms in the newborn child.
Absolute Contraindications
Do not consume or prescribe the G037 tablet if the patient exhibits:
- Significant respiratory depression, hypercapnia (excess carbon dioxide in the blood), or severe, uncontrolled bronchial asthma.
- Known or suspected gastrointestinal obstruction, specifically paralytic ileus (paralyzed bowel movement).
- A documented allergy or systemic hypersensitivity to hydrocodone, acetaminophen, or closely related semi-synthetic opioids.
Critical Drug Interactions
- Alcohol & Depressants: Mixing this medication with alcohol, anti-anxiety medications (such as benzodiazepines like Xanax or Valium), or muscle relaxants can induce deep coma, profound respiratory arrest, and death.
- CYP3A4 Inhibitors: Medications that slow down liver metabolism (like ketoconazole, clarithromycin, or grapefruit juice) can dramatically elevate hydrocodone levels in the bloodstream, increasing the risk of a fatal overdose.